欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1530/001
药品名称
Hydroxyzine Bluefish
活性成分
Hydroxyzine hydrochloride 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Bluefish Pharmaceuticals AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Norway (NO)
Hydroxyzine Bluefish
Poland (PL)
Hydroxyzine Bluefish
France (FR)
许可日期
2016/02/22
最近更新日期
2024/09/24
药物ATC编码
N05BB01 hydroxyzine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
SE_H_1530_001_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1530_001_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase